#
Artículo
URL
1
Epidemiología, causas, manifestación clínica y diagnóstico, prevención y control de la enfermedad por coronavirus (COVID19) durante el período de brote temprano: una revisión del alcance
2
SARS-CoV-2 and COVID-19 A new virus and associated respiratory disease
3
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
4
Structure of the SARS CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
5
Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses
6
Functional analysis of potential cleavage sites in the MERScoronavirus spike protein
7
Origin and evolution of pathogenic coronaviruses
8
Attenuation of replication by a 29 nucleotide deletion in SARScoronavirus acquired during the early stages of human-tohuman transmission
9
Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis
10
Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform
11
SARS and MERS: recent insights into emerging coronaviruses
12
SARS coronavirus papain-like protease induces Egr-1dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway
13
Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity
14
Coronaviruses — drug discovery and therapeutic options
15
Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)
16
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
17
Pre-fusion structure of a human coronavirus spike protein
18
A decade after SARS: strategies for controlling emerging coronaviruses
19
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
20
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
21
2019 Novel Coronavirus: Where We are and What We Know.
22
Another Decade, Another Coronavirus.
23
The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.
24
Coronavirus: A Mini-Review
25
Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed
26
Compilación de artículos científicos sobre COVID-19
27
What are the risks of COVID-19 infection in pregnant women?
28
Consistent Detection of 2019 Novel Coronavirus in Saliva
29
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
30
Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea.
31
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
32
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
33
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:a descriptive study
34
Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam
35
Emerging understandings of 2019-nCoV
36
Data sharing and outbreaks: best practice exemplified
37
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
38
A novel coronavirus outbreak of global health concern
39
Coronavirus Infections—More Than Just the Common Cold
40
COVID-19 Artículos científicos
41
Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19
42
Coronavirus (Covid-19)
43
Todo lo que debes saber del coronavirus
44
¿QUé son los coronavirus?
45
COVID-19 - ICU (1.0)
46
Crippled community governance and suppressed scientific/professional communities: a critical assessment of failed early warning for the COVID-19 outbreak in China
47
Responding to community spread of COVID-19
48
COVID-19 Docking Server: An interactive server for docking small molecules, peptides and antibodies against potential targets of COVID-19
49
A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry
50
Virtual Screening of an FDA Approved Drugs Database on Two COVID-19 Coronavirus Proteins
51
Orientación a entornos educativos sobre COVID-19. Actualizado 26 de febrero de 2020
52
UMB_UMMS Políticas y orientación sobre COVID-19
53
Molecular Docking Study of Novel COVID-19 Protease with Low Risk Terpenoides Compounds of Plants
54
Pronóstico de inteligencia artificial de Covid-19 en China
55
Risk communication and community engagement (RCCE) readiness and response to the 2019 novel coronaviruses (2019nCoV): interim guidance, 26 January 2020
56
Risk communication and community engagement readiness and initial response for novel coronaviruses (nCoV): interim guidance, 26 January 2020
57
Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection: interim guidance, 10 January 2020
58
Responding to community spread of COVID-19
59
Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19
60
Las 6 preguntas clave (y sus respuestas) sobre el coronavirus
61
Similitudes y relaciones evolutivas de COVID-19 y virus relacionados
62
Infecciones por coronavirus
63
Modelando el Control de COVID-19: Impacto de Intervenciones de Políticas y Factores Meteorológicos
64
Análisis de datos para la dinámica temprana de COVID-19 en el norte de Italia
65
Regulación de la producción de interferón como estrategia potencial para el tratamiento con COVID-19
66
Abrazando la complejidad: COVID-19 es un caso para la colaboración académica y la co-creación.
67
Covid-19: la nueva enfermedad causada por un coronavirus
68
Manifestaciones por TC de dos casos de neumonía por coronavirus novedoso de 2019 (2019-nCoV)
69
Características epidemiológicas y clínicas de 99 casos de neumonía por coronavirus novedosa de 2019 en Wuhan, China: un estudio descriptivo
70
Comunicar el riesgo de muerte por nueva enfermedad de coronavirus (COVID-19)
71
¿Qué más se debe hacer para controlar los brotes de COVID-19 además de las medidas de aislamiento de casos y localización de contactos?
72
Difusión mundial de COVID-19 y potencial pandémico
73
Evaluación del impacto de los viajes reducidos en la dinámica de exportación de la infección por nuevos coronavirus (COVID19)
74
Volviéndose viral: evaluación de impacto de Covid-19: una perspectiva más allá de la práctica clínica
75
Enfermedad por coronavirus (COVID-19): la necesidad de mantener una actividad física regular mientras se toman precauciones
76
Nuevo Coronavirus (nCoV) 2019-2020 Algunos conceptos
77
Algunos estados informan resultados incompletos de COVID-19, borrando la imagen completa
78
Cómo la sangre de los sobrevivientes de coronavirus podría salvar vidas
79
¿Cómo prevenimos el próximo brote?
80
El aumento exponencial de la infección es mortal grave
81
COVID-19: prediciendo el camino y analizando la inmunidad
82
Una causa fundamental de las pandemias Pocas personas piensan
83
Pruebas rápidas y portátiles entran en línea para frenar la pandemia de coronavirus
84
La ONU cambia del cambio climático al coronavirus
85
Cuando es más seguro mantenerse alejado
86
¿Qué es más aterrador que el coronavirus?
87
¿Ha llegado finalmente el día de la telemedicina?
88
Falsa esperanza sobre los tratamientos con coronavirus
89
Vacunas contra el coronavirus: cinco preguntas clave a medida que comienzan los ensayos
90
Impactos psicosociales de COVID-19
91
Las infecciones encubiertas del coronavirus podrían estar generando nuevos brotes
92
Esas precauciones para evitar el coronavirus pueden parecer extremas, pero ...
93
Cómo los cazadores de drogas COVID-19 detectan compuestos para combatir virus
94
Los estudiantes de medicina deben salir del hospital ahora
95
Lecciones de brotes pasados podrían ayudar a combatir la pandemia de coronavirus
96
Larry Brilliant ayudó a erradicar la viruela, y tiene consejos para COVID-19
97
Coronavirus 2020 [Originalmente publicado como editorial en Revista Brasileira de Enfermagem vol. 73 no. 2]
98
Pagina principal para ingresar a la colección de Elsevier
99
Características clínicas y potencial de transmisión vertical intrauterina de la infección por COVID-19 en nueve mujeres embarazadas.
100
Artículos de coronavirus en animales y de años pasados
102
Preguntas y respuestas sobre la enfermedad por coronavirus (COVID-19)
103
Nuevo coronavirus 2019-ncov: impacto en salud global
104
Un ensayo de lopinavir-ritonavir en adultos hospitalizados con covid-19 grave
105
Síndrome respiratorio de Medio Oriente (MERS)
106
Presunta transmisión portadora asintomática de COVID-19
107
COVID-19: evidencia respalda período de incubación de cinco días
108
Nuevo coronavirus, la epidemia
109
Las características epidemiológicas de un brote de nuevas enfermedades por coronavirus 2019 (COVID-19) en China.
110
Presunta transmisión portadora asintomática de COVID-19
111
Infección por coronavirus asociada al síndrome respiratorio agudo severo asintomático
112
El nuevo brote de coronavirus (COVID-2019): amplificación de las consecuencias para la salud pública por exposición a los medios
113
Crianza de los hijos en un momento de COVID-19
114
El efecto de las estrategias de control para reducir la mezcla social en los resultados de la epidemia COVID-19 en Wuhan, China: un estudio de modelado
115
COVID-19: medidas de control de distanciamiento que se extienden o relajan
116
Características clínicas y epidemiológicas de 36 niños con enfermedad por coronavirus 2019 (COVID-19) en Zhejiang, China: un estudio de cohorte observacional
117
COVID-19 en niños: el eslabón en la cadena de transmisión
118
El papel de la TC en la determinación y el manejo de casos de neumonía por COVID-19 en el Reino Unido: ideas de regiones de alta incidencia
119
Las pautas oficiales francesas para proteger a los pacientes con cáncer contra la infección por SARS-CoV-2
120
Desafíos planteados por COVID-19 a niños con cáncer
121
Detección viral antes del inicio de productos biológicos en pacientes con enfermedad inflamatoria intestinal durante el brote de COVID-19
122
El sistema de salud italiano y el desafío COVID-19
123
Programa nacional de trabajadores comunitarios de salud del Reino Unido para la respuesta COVID-19
124
Características y lecciones importantes del brote de la enfermedad por coronavirus 2019 (COVID-19) en China
125
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan
126
Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)
127
What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures?
128
Global spread of COVID-19 and pandemic potential
129
Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19)
130
Going viral – Covid-19 impact assessment: A perspective beyond clinical practice
131
Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions
132
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review
133
Critical preparedness, readiness and response actions for COVID-19: interim guidance, 7 March 2020
134
Coronavirus disease 2019 (COVID-19): situation report, 31
135
Global surveillance for COVID-19 disease caused by human infection with novel coronavirus (COVID-19): interim guidance, 27 February 2020
136
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
137
Laboratory Diagnosis of Emerging Human Coronavirus Infections — The State of the Art
138
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
139
One Health approach and Coronavirus Disease 2019
140
Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals
141
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
142
The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19
143
Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
144
Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins
145
Epidemias y pandemias: una realidad para el siglo XXI. Un mundo y una salud
146
Length-scale dependence of protein hydration-shell density
147
A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias.
148
Coronavirus Disease 2019: Coronaviruses and Blood Safety
149
Coronavirus Disease 2019 (COVID‐19): What we know?
150
Coronavirus research. Research projects and initiatives to tackle the spread of coronavirus and preparedness for other outbreaks.
151
La Atención Primaria de Salud: Más necesaria que nunca en la crisis del Coronavirus
152
Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible
153
How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?
154
Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey
155
Annals On Call - Understanding the Spread of COVID-19
156
Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.
157
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.
158
Genomic Study Points to Natural Origin of COVID-19
159
To Beat COVID-19, Social Distancing is a Must
160
COVID-19 pneumonia: infection control protocol inside computed tomography suites
161
Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic
162
The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease 2019 (COVID-19) in January and February 2020 in China.
163
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation
164
Coronavirus Disease 2019 (COVID-19): A Perspective from China
165
A Review of Coronavirus Disease-2019 (COVID-19)
166
The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 （COVID-19） and Its Research Progress in Forensic Toxicology.
167
Caregiver oral health literacy: relationship with socioeconomic factors, oral health behaviors and perceived child dental status.
168
Coronavirus Disease 2019 in Geriatrics and Long-term Care: The ABCDs of COVID-19.
169
DOCUMENTO DE MANEJO CLINICO DEL PACIENTE PEDIÁTRICO CON INFECCION POR SARS-CoV-2
170
Recomendaciones para el manejo del recién nacido en relación con la infección por SARS-CoV-2.
171
One world, one health: The novel coronavirus COVID-19 epidemic
172
Coronavirus y Riñón
173
Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics
174
Novel coronavirus pneumonia
175
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients
176
BASES EPIDEMIOLÓGICAS PARA LA TOMA DE DECISIONES SOBRE MEDIDAS DE SALUD PÚBLICA (NO FARMACOLÓGICAS) DURANTE LA RESPUESTAA LA PANDEMIA DE GRIPE (H1N1) 2009
177
COVID-19: GENERAL GUIDELINES FOR CARDIOVASCULAR SURGEONS (standard guidelines – subject to change)
178
Generalidades de la Pandemia por COVID-19 y su asociación genética con el virus del SARS
179
Primeras lecciones de la pandemia de COVID-19 a la educación médica colombiana
180
Cuidados intensivos durante la epidemia de coronavirus 2019
181
Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infeccion por SARS-CoV-2
182
¿Cumplimos correctamente los protocolos de prevención en oftalmología?: a propósito de la última epidemia por coronavirus
183
Actualización de la situación epidemiológica de la infección por SARS-CoV-2 en España. Comentarios a las recomendaciones de manejo de la infección en pediatría
184
La maldita pandemia: una oportunidad para la Atención Primaria de Salud
185
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
186
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
187
Q&A: The novel coronavirus outbreak causing COVID-19
188
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
189
Coronaviruses
190
The Role of Bats as Reservoir Hosts of Emerging Neuroviruses
191
Emerging Animal Coronaviruses: First SARS and Now MERS
192
Containing 2019-nCoV (Wuhan) coronavirus
193
Preparing for COVID-19: early experience from an intensive care unit in Singapore
194
The proximal origin of SARS-CoV-2
195
Antivirals in medical biodefense
196
A pneumonia outbreak associated with a new coronavirus of probable bat origin
197
A new coronavirus associated with human respiratory disease in China
198
A mouse model for MERS coronavirus-induced acute respiratory distress syndrome
199
Structural basis for human coronavirus attachment to sialic acid receptors
200
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
201
Medidas higiénicas para la prevención y manejo ambulatorio de contagios por Covid-19
201
Infección respiratoria aguda por COVID-19: una amenaza evidente
202
Covid-19 is reshaping the world of bioscience publishing
203
The Covid-19 crisis too few are talking about: health care workers’ mental health
204
A nurse’s coronavirus routine: Recording videos she hopes her family will never need to watch
205
I got Covid-19 and got lucky. The emotional impact hurt more
206
Coronavirus latest: confirmed cases cross the one-million mark
207
Pick of the coronavirus papers: Masks could cut spread of COVID-19 virus
208
Special report: The simulations driving the world’s response to COVID-19
209
Is the coronavirus airborne? Experts can’t agree
210
How poorer countries are scrambling to prevent a coronavirus disaster
211
‘We need to be alert’: Scientists fear second coronavirus wave as China’s lockdowns ease
212
Should scientists infect healthy people with the coronavirus to test vaccines?
213
How blood from coronavirus survivors might save lives
214
A Sentinel COVID‐19 Case in Houston, Texas: Informing Frontline Emergency Department Screening and Preparedness
215
Respiratory Support for Adult Patients with COVID‐19
216
Response to: Sore throat in COVID‐19: comment on “Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis”
217
How young patients with cancer perceive the Covid‐19 (coronavirus) epidemic in Milan, Italy: is there room for other fears?
218
Early advice on managing children with cancer during the COVID‐19 pandemic and a call for sharing experiences
219
COVID‐19 in a Designated Infectious Diseases Hospital Outside Hubei Province, China
220
Converting gas‐driven ventilators from oxygen to air
221
Older people and COVID‐19: Isolation, risk and ageism
222
The versatile heparin in COVID‐19
223
AMA COVID‐19 recommendations: MAT, pain and harm reduction
224
COVID‐19 Pneumonia as a Cause of Acute Chest Syndrome in an Adult Sickle Cell Patient
225
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies
226
COVID‐19 in Turkey: An urgent need for the implementation of preparedness and response strategies
227
Neutrophil‐to‐Lymphocyte ratio and Lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis
228
Detection of antibodies against SARS‐CoV‐2 in patients with COVID‐19
229
Insight into 2019 novel coronavirus — an updated intrim review and lessons from SARS-CoV and MERS-CoV
230
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
231
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
232
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
233
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
234
Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus
235
Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong
236
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA
237
Molecular immune pathogenesis and diagnosis of COVID-19
238
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
239
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
240
COVID-19 precautionary behavior: The Israeli case in the initial stage of the outbreak
241
Clinical characteristics of 208 patients with COVID-19 in a surrounding city of Wuhan, China
242
Chest CT for Detecting COVID-19: A Systematic Review and Meta-Analysis of Diagnostic Accuracy
243
A case report and summary of thrombocytopenia caused by coronavirus disease 2019
244
CT features and artificial intelligence quantitative analysis of recovered COVID-19 patients with negative RT-PCR and clinical symptoms
245
Truncated Inception Net: COVID-19 Outbreak Screening using Chest X-rays
246
SARS-CoV-2 Preimmune IgM Epitopes
247
Cases Report of Cured Novel Coronavirus-infected Pneumonia Patients with Viral Nucleic Acid Test Positive in Fecal Specimens
248
Computerized tomography scan findings of a patient with severe enterocolitis associated with the coronavirus disease 2019: a case report
249
D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study
250
Clinical course and features of critical patients with COVID-19: a single-center, retrospective study from Wuhan Huoshenshan Hospital
251
COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases
252
Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
253
Reflexiones derivadas de la pandemia COVID-19
254
Coronavirus y atención primaria
255
Recomendaciones de “hacer” y “no hacer” en el tratamiento de los pacientes críticos ante la pandemia por coronavirus causante de COVID-19 de los Grupos de Trabajo de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC)
256
Covid-19 con afectacion pulmonar. Una enfermedad autoinmune de causa conocida
257
Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal
258
Coronavirus y Riñón. Últimas Novedades 1 de Abril de 2020
259
Controversias sobre el tratamiento con IECA/ARA-II y Covid-19
260
Miocarditis fulminante por COVID-19
261
Exercising in times of COVID-19: what do experts recommend doing within four walls?
262
Dosificación de Fármacos en Enfermos con Coronavirus
263
RECOMENDACIONES DE CONSENSO SEPAR – AEER SOBRE LA UTILIDAD DE LA ECOGRAFIA TORACICA EN EL MANEJO DEL ´ PACIENTE CON SOSPECHA O INFECCION CONFIRMADA CON COVID-19
264
Impacto de la pandemia por SARS-CoV-2 sobre la actividad y profesionales de un Servicio de Cirug´ıa General y del Aparato Digestivo en un hospital terciario
265
Respuesta a la carta: Crisis Sanitaria COVID-19: el papel de un cirujano
266
Crisis Sanitaria COVID-19: el papel de un cirujano
267
Extensión y cuantificación de la carga inflamatoria en COVID-19 mediante tomografía computarizada
268
Distance learning and telemedicine in the area of Otorhinolaryngology: lessons in times of pandemic
269
¿Es esperable que haya cuadros neurologicos por la pandemia de SARS2-CoV?
270
Coronavirus y atencion primaria
271
Cuidado Respiratorio En Covid-19
272
El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo
273
Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus
274
Search for polyoma-, herpes-, and bornaviruses in squirrels of the family Sciuridae
275
Characterization of antibiotic resistance and host-microbiome interactions in the human upper respiratory tract during influenza infection
276
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
277
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
278
A viral theory of post-truth
279
Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach
280
The management of biologics in dermatologic patients in the 2019-nCoV era
281
Biological treatment during COVID-19 outbreak
282
Teledermatology: a useful tool to fight COVID-19
283
Grandparent contact: another presumption?
284
Including people with disability in the COVID-19 outbreak emergency preparedness and response in China
285
Emergence of Novel Coronavirus and COVID-19: whether to stay or die out?
286
Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
287
Guide to forensic pathology practice for death cases related to coronavirus disease 2019 (COVID-19) (Trial draft)
288
Corporate expertise can help nonprofits weather pandemic
289
DOT announces $25B to respond to COVID‐19
290
Reply to: “Reporting of all cardiac medications and their outcome in COVID‐19”
291
Influenza‐like illnesses caused by a cluster of imported Italian COVID‐19
292
COVID‐19: Herd Immunity and Convalescent Plasma Transfer Therapy
293
C‐reactive protein correlates with CT findings and predicts severe COVID‐19 early
294
Coronavirus disease 2019: new things to know!
295
Integrated Hospital Quarantine System against COVID‐19
296
Small Business Administration emergency loans available for nonprofits
297
Delayed Initiation of Remdesivir in a COVID‐19 Positive Patient
298
Treatment considerations for coronavirus (COVID-19)
299
Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review
300
Preparing an obstetric unit in the heart of the epidemic strike of COVID-19: quick reorganization tips
301
ASM Submits Letter to FDA Calling for Stronger Oversight of COVID-19 Serology Tests
302
Verify Emergency Use Authorization (EUA) COVID-19 Diagnostic Test
303
ASM Leads Stakeholder Letter Urging a Review of COVID-19 Response to Prepare for Future Pandemics
304
ASM COVID-19 International Summit Sets Research Priorities
305
Breakdown of the Coronavirus Aid, Relief, and Economic Security (CARES) Act
306
Researchers Investigate Potential Treatments for COVID-19
307
ASM Commends New Guidance to Increase COVID-19 Testing Capacity
308
A Possible Treatment for COVID-19 and an Approach for Developing Others
309
ASM Expresses Concern about Coronavirus Test Reagent Shortages
310
What to Know About the New Coronavirus: An Interview with Dr. Stanley Perlman
311
Informações sobre o novo coronavírus (COVID-19)
312
Covid-19 — Navigating the Uncharted
313
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
314
Clinical Characteristics of Coronavirus Disease 2019 in China
315
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
316
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
317
Compassionate Use of Remdesivir for Patients with Severe Covid-19
318
Phylogenetic network analysis of SARS-CoV-2 genomes
319
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
320
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
321
Rational use of face masks in the COVID-19 pandemic
322
COVID-19: protecting health-care workers
323
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
324
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
325
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
326
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications
327
Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)
328
COVID-19: too little, too late?
329
SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
330
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters
331
The COVID-19 vaccine development landscape
332
Infeccion Por Sars-Cov-2 En La Paciente Obstetrica: Una Perspectiva Desde El Cuidado Critico
333
Recomendaciones de la Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello para la realización de traqueotomías en relación con pacientes infectados por coronavirus COVID-19
334
An update on COVID-19 for the otorhinolaryngologist – a Brazilian Association of Otolaryngology and Cervicofacial Surgery (ABORL-CCF) Position Statement
335
COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals
336
Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19
337
Beware: Gastrointestinal symptoms can be a manifestation of COVID-19
338
¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
339
The intriguing features of COVID-19 in children and its impact on the pandemic
340
Viability of intertwined supply networks: extending the supply chain resilience angles towards survivability. A position paper motivated by COVID-19 outbreak
341
In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
342
An assessment of United States dermatology practices during the COVID-19 outbreak
343
China's economic strategy: when theory meets practice
344
JLT and the Coronavirus
345
How simulation modelling can help reduce the impact of COVID-19
346
China’s Dilemmas over Stalled North Korean Denuclearization Talks
347
COVID-19: Challenges and opportunities for dermatology response
348
Dapsone as treatment adjunct in ARDS
349
Coronavirus Research Trends: A 50–Year Bibliometric Assessment
350
Editor’s introduction: Our public service manifesto during pandemic
351
Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?
352
Communication related health crisis on social media: a case of COVID-19 outbreak
353
Soccer, World War II and coronavirus: a comparative analysis of how the sport shut down
354
Pandemic pressure: policy, politics, profession, and rapid publication
355
Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?
356
Public governance mechanism in the prevention and control of the COVID-19: information, decision-making and execution
357
Significance of Serology Testing to Assist Timely Diagnosis of SARS-CoV-2 infections: Implication from a Family Cluster
358
A viral theory of post-truth
359
Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach
360
Situacion de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo Informe del Registro COVID-19 de la Sociedad Española de Nefrología (S.E.N.)
361
Pandemia de Covid-19 y transformacion digital en Cuidados Intensivos
362
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
363
Nuevo coronavirus (2019-nCov): ¿tiene suficientes unidades de cuidados intensivos?
364
Recomendaciones eticas para la toma de decisiones difíciles en las unidades de cuidados intensivos ante la situacion excepcional de crisis por la pandemia por covid-19: revision rápida y consenso de expertos
365
Letalidad del COVID-19: ausencia de patron epidemiológico
366
Coronavirus–associated enteritis in a quail farm
367
Broad-spectrum coronavirus antiviral drug discovery
368
Coronavirus HKU15 in respiratory tract of pigs and first discovery of coronavirus quasispecies in 5′-untranslated region
369
Coronavirus Research Trends: A 50–Year Bibliometric Assessment
370
Antiviral applications of RNAi for coronavirus
371
Coronavirus NSP6 restricts autophagosome expansion
372
Coronavirus disinfection in histopathology
373
Developments in the laboratory diagnosis of SARS—coronavirus infections
374
2019 novel coronavirus: an emerging global threat
375
Molecular Dynamics Simulations of Various Coronavirus Main Proteinases
376
On the alert for cytokine storm: Immunopathology in COVID‐19
377
Global guidance for surgical care during the COVID‐19 pandemic
378
Moving biochemistry and molecular biology courses online in times of disruption: Recommended practices and resources ‐ a collaboration with the faculty community and ASBMB
379
Coronavirus and the hearts of doctors
380
Coronavirus, Climate Change, and a Bit of Hope
381
Could HIV infection alter the clinical course of SARS‐CoV‐2 infection? When less is better
382
Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China
383
Clinical characteristics of 3,062 COVID‐19 patients: a meta‐analysis
384
Possibly critical role of wearing masks in general population in controlling COVID‐19
385
Hyperglycemia, Hydroxychloroquine, and the COVID‐19 Epidemic
386
Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019
387
Does COVID‐19 Disprove the Obesity Paradox in ARDS?
388
The Impact of COVID‐19 on Bariatric Surgery: Re‐Defining Psychosocial Care
389
The impact of COPD and smoking history on the severity of Covid‐19: A systemic review and meta‐analysis
390
Coinfection with COVID‐19 and Coronavirus HKU1 – the critical need for repeat testing if clinically indicated
391
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
392
Coronaviruses and SARS-CoV-2: A Brief Overview.
393
Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective
394
Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspected or Confirmed SARS-CoV-2 Infection
395
Updating the diagnostic criteria of COVID-19 “suspected case” and “confirmed case” is necessary
396
Commonwealth Update
397
Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study
398
COVID-19: fear appeal favoring purchase behavior towards personal protective equipment
399
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
400
SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill